| Application number | Title of the application | Filing Date | Status |
|---|
| 08/703738 | METHODS AND COMPOSITIONS FOR TREATING ASTHMA, ATHEROSCLEROSIS AND INFLAMMATORY DISEASES USING OPTICALLY PURE (+)-ZILEUTON | Aug 26, 1996 | Abandoned |
Array
(
[id] => 3887102
[patent_doc_number] => 05714486
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-03
[patent_title] => 'Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/695103
[patent_app_country] => US
[patent_app_date] => 1996-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5590
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/714/05714486.pdf
[firstpage_image] =>[orig_patent_app_number] => 695103
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/695103 | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives | Aug 6, 1996 | Issued |
Array
(
[id] => 3728380
[patent_doc_number] => 05703077
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-30
[patent_title] => 'Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/693745
[patent_app_country] => US
[patent_app_date] => 1996-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5599
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/703/05703077.pdf
[firstpage_image] =>[orig_patent_app_number] => 693745
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/693745 | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives | Aug 6, 1996 | Issued |
Array
(
[id] => 3886682
[patent_doc_number] => 05776956
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'Use of cotinine in treating psychiatric disorders'
[patent_app_type] => 1
[patent_app_number] => 8/688363
[patent_app_country] => US
[patent_app_date] => 1996-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11941
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/776/05776956.pdf
[firstpage_image] =>[orig_patent_app_number] => 688363
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/688363 | Use of cotinine in treating psychiatric disorders | Jul 29, 1996 | Issued |
Array
(
[id] => 3994210
[patent_doc_number] => 05858413
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Antacid composition, substantially free of preservatives'
[patent_app_type] => 1
[patent_app_number] => 8/685377
[patent_app_country] => US
[patent_app_date] => 1996-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2918
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858413.pdf
[firstpage_image] =>[orig_patent_app_number] => 685377
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/685377 | Antacid composition, substantially free of preservatives | Jul 22, 1996 | Issued |
Array
(
[id] => 3950245
[patent_doc_number] => 05955479
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Levobupivacaine for managing chronic pain'
[patent_app_type] => 1
[patent_app_number] => 8/628689
[patent_app_country] => US
[patent_app_date] => 1996-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1688
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955479.pdf
[firstpage_image] =>[orig_patent_app_number] => 628689
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/628689 | Levobupivacaine for managing chronic pain | Jul 21, 1996 | Issued |
Array
(
[id] => 3792772
[patent_doc_number] => 05726163
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-10
[patent_title] => 'Dermatologic composition'
[patent_app_type] => 1
[patent_app_number] => 8/676253
[patent_app_country] => US
[patent_app_date] => 1996-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1991
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/726/05726163.pdf
[firstpage_image] =>[orig_patent_app_number] => 676253
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/676253 | Dermatologic composition | Jul 16, 1996 | Issued |
Array
(
[id] => 3629118
[patent_doc_number] => 05686475
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-11
[patent_title] => 'Application of riluzole in the treatment of mitochondrial diseases'
[patent_app_type] => 1
[patent_app_number] => 8/669530
[patent_app_country] => US
[patent_app_date] => 1996-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1514
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/686/05686475.pdf
[firstpage_image] =>[orig_patent_app_number] => 669530
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/669530 | Application of riluzole in the treatment of mitochondrial diseases | Jul 10, 1996 | Issued |
Array
(
[id] => 3761386
[patent_doc_number] => 05843936
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'Topical administration of azaspiranes to prevent or treat skin conditions associated with hyperproliferation of keratinocytes'
[patent_app_type] => 1
[patent_app_number] => 8/672728
[patent_app_country] => US
[patent_app_date] => 1996-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4396
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843936.pdf
[firstpage_image] =>[orig_patent_app_number] => 672728
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/672728 | Topical administration of azaspiranes to prevent or treat skin conditions associated with hyperproliferation of keratinocytes | Jun 27, 1996 | Issued |
| 08/673341 | USEFUL FORMULATIONS OF ACID ADDITION SALT DRUGS | Jun 27, 1996 | Abandoned |
Array
(
[id] => 3667183
[patent_doc_number] => 05599846
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-04
[patent_title] => 'Phenylephrine tannate compositions'
[patent_app_type] => 1
[patent_app_number] => 8/671160
[patent_app_country] => US
[patent_app_date] => 1996-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2001
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/599/05599846.pdf
[firstpage_image] =>[orig_patent_app_number] => 671160
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/671160 | Phenylephrine tannate compositions | Jun 27, 1996 | Issued |
Array
(
[id] => 3887420
[patent_doc_number] => 05714505
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-03
[patent_title] => 'Method for treatment of psoriasis, by omeprazole or related compounds'
[patent_app_type] => 1
[patent_app_number] => 8/666504
[patent_app_country] => US
[patent_app_date] => 1996-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1248
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/714/05714505.pdf
[firstpage_image] =>[orig_patent_app_number] => 666504
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/666504 | Method for treatment of psoriasis, by omeprazole or related compounds | Jun 23, 1996 | Issued |
Array
(
[id] => 4064741
[patent_doc_number] => 05866581
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'Penciclovir for the treatment of post therapeutic neuralgia'
[patent_app_type] => 1
[patent_app_number] => 8/624466
[patent_app_country] => US
[patent_app_date] => 1996-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7356
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866581.pdf
[firstpage_image] =>[orig_patent_app_number] => 624466
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/624466 | Penciclovir for the treatment of post therapeutic neuralgia | Jun 19, 1996 | Issued |
| 08/666852 | MEMORY ENHANCING AND ANTI-DEMENTIA AGENT CONTAINING DEHYDROEVODIAMINE- HCL AS ACTIVE INGREDIENT | Jun 18, 1996 | Abandoned |
Array
(
[id] => 3934183
[patent_doc_number] => 05871779
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'Treatment of arthropathies with vanadate compounds or analogues thereof'
[patent_app_type] => 1
[patent_app_number] => 8/662859
[patent_app_country] => US
[patent_app_date] => 1996-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 15823
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/871/05871779.pdf
[firstpage_image] =>[orig_patent_app_number] => 662859
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/662859 | Treatment of arthropathies with vanadate compounds or analogues thereof | Jun 11, 1996 | Issued |
Array
(
[id] => 3838785
[patent_doc_number] => 05847003
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-08
[patent_title] => 'Oxa acids and related compounds for treating skin conditions'
[patent_app_type] => 1
[patent_app_number] => 8/658089
[patent_app_country] => US
[patent_app_date] => 1996-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6948
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/847/05847003.pdf
[firstpage_image] =>[orig_patent_app_number] => 658089
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/658089 | Oxa acids and related compounds for treating skin conditions | Jun 3, 1996 | Issued |
Array
(
[id] => 3829697
[patent_doc_number] => 05739159
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-14
[patent_title] => 'Medicaments for the treatment of cardiac insufficiency'
[patent_app_type] => 1
[patent_app_number] => 8/652502
[patent_app_country] => US
[patent_app_date] => 1996-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1543
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/739/05739159.pdf
[firstpage_image] =>[orig_patent_app_number] => 652502
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/652502 | Medicaments for the treatment of cardiac insufficiency | May 30, 1996 | Issued |
Array
(
[id] => 3890225
[patent_doc_number] => 05750150
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-12
[patent_title] => 'Compositions for treating affected tissues, method for the preparation and usage thereof'
[patent_app_type] => 1
[patent_app_number] => 8/652648
[patent_app_country] => US
[patent_app_date] => 1996-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14749
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/750/05750150.pdf
[firstpage_image] =>[orig_patent_app_number] => 652648
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/652648 | Compositions for treating affected tissues, method for the preparation and usage thereof | May 27, 1996 | Issued |
| 08/652484 | SSI TYRPHOSTINS AND PHARMACEUTICAL COMPOSITIONS | May 22, 1996 | Abandoned |
Array
(
[id] => 4048868
[patent_doc_number] => 05869525
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-09
[patent_title] => 'Ascorbic acid drugs for intracerebral administration'
[patent_app_type] => 1
[patent_app_number] => 8/647767
[patent_app_country] => US
[patent_app_date] => 1996-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5276
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/869/05869525.pdf
[firstpage_image] =>[orig_patent_app_number] => 647767
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/647767 | Ascorbic acid drugs for intracerebral administration | May 14, 1996 | Issued |